XOMA to Announce Third Quarter 2013 Financial Results and Host Webcast on November 7 Oct 31, 2013 5:00pm EDT
Results From Two Phase 2 Studies in XOMA's Gevokizumab Proof-of-Concept Program Are Very Encouraging and Compelling Oct 30, 2013 4:42pm EDT
XOMA Announces Closing of the Offering and Exercise of Over-Allotment Option Aug 23, 2013 12:12pm EDT
XOMA Highlights Recent Achievements and Reports Financial Results for Second Quarter 2013 Aug 07, 2013 4:01pm EDT
XOMA to Announce Second Quarter 2013 Financial Results and Host Webcast on August 7 Jul 25, 2013 9:00am EDT
XOMA Completes Enrollment in Phase 2 Proof-of-Concept Gevokizumab Trial in Patients With Erosive Osteoarthritis of the Hand Jul 22, 2013 8:00am EDT
